Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M829Revenue $M330Net Margin (%)0.1Z-Score1.9
Enterprise Value $M889EPS $-0.2Operating Margin %-0.1F-Score8
P/E(ttm))1,126Cash Flow Per Share $0.1Pre-tax Margin (%)0.2Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %0Quick Ratio1.9Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %0Current Ratio2.7Lower Leverage y-yY
Price/Cash Flow43.2y-y EBITDA Growth Rate %142ROA % (ttm)0.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M73.6ROI % (ttm)-13.6Gross Margin Increase y-yY

Gurus Latest Trades with AFFX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AFFXJoel Greenblatt 2014-09-30 Sold Out -0.01%$7.98 - $9.36
($8.57)
$ 11.2631%Sold Out0
AFFXJoel Greenblatt 2014-06-30 Reduce-0.01%$6.37 - $9.419
($7.94)
$ 11.2642%Reduce -52.04%72,552
AFFXJoel Greenblatt 2014-03-31 Add0.01%$6.65 - $9.5
($8.09)
$ 11.2639%Add 385.09%151,285
AFFXPRIMECAP Management 2013-12-31 Add0.03%$6.35 - $8.85
($7.67)
$ 11.2647%Add 31.13%10,666,640
AFFXJoel Greenblatt 2013-12-31 Reduce-0.05%$6.35 - $8.85
($7.67)
$ 11.2647%Reduce -88.37%31,187
AFFXJoel Greenblatt 2013-09-30 Buy 0.05%$3.78 - $6.3
($5.16)
$ 11.26118%New holding, 268084 sh.268,084
AFFXPRIMECAP Management 2013-09-30 Add0.01%$3.78 - $6.3
($5.16)
$ 11.26118%Add 22.94%8,134,440
AFFXJoel Greenblatt 2012-09-30 Sold Out -0.06%$3.61 - $4.7
($4.17)
$ 11.26170%Sold Out0
AFFXPRIMECAP Management 2012-06-30 Add0.03%$4.01 - $5.11
($4.6)
$ 11.26145%Add 149.79%7,025,440
AFFXJoel Greenblatt 2012-06-30 Reduce-0.07%$4.01 - $5.11
($4.6)
$ 11.26145%Reduce -50.63%175,755
AFFXJoel Greenblatt 2012-03-31 Add0.05%$4.11 - $5.21
($4.19)
$ 11.26169%Add 67.73%356,011
AFFXJoel Greenblatt 2011-12-31 Add0.05%$3.7 - $5.83
($4.78)
$ 11.26136%Add 92.44%212,251
AFFXJoel Greenblatt 2011-09-30 Buy 0.09%$4.14 - $8
($5.6)
$ 11.26101%New holding, 110294 sh.110,294
AFFXJoel Greenblatt 2011-06-30 Sold Out -0.02%$5.01 - $7.85
($6.29)
$ 11.2679%Sold Out0
AFFXJoel Greenblatt 2011-03-31 Buy 0.02%$4.45 - $5.53
($4.97)
$ 11.26127%New holding, 15174 sh.15,174
AFFXCharles Brandes 2010-06-30 Sold Out $5.81 - $8.33
($6.79)
$ 11.2666%Sold Out0
AFFXCharles Brandes 2010-03-31 Buy $5.28 - $7.98
($6.92)
$ 11.2663%New holding, 32040 sh.32,040
AFFXMeridian Funds 2008-12-31 Sold Out -0.38%$2.16 - $5.44
($3.3)
$ 11.26241%Sold Out0
AFFXMeridian Funds 2008-09-30 Add0.34%$7.61 - $10.43
($8.8)
$ 11.2628%Add 787.13%1,281,900
AFFXMeridian Funds 2008-06-30 Buy 0.05%$10.06 - $17.11
($12.2)
$ 11.26-8%New holding, 144500 sh.144,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AFFX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AFFX PRIMECAP Management 2014-09-3010,559,24014.350.09
AFFX Joel Greenblatt 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


AFFX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Wood GavinEVP, CFO 2015-01-20Sell22,500$11.77-4.33view
Wood GavinEVP, CFO 2014-12-29Sell18,734$10.210.39view
Trice Robert HDirector 2013-11-19Sell6,205$7.9841.1view
Wood GavinCFO 2013-05-20Sell0$041.1view
Weber David AEVP, Commercial Operations 2013-02-12Sell0$041.1view
BARABE TIMOTHY CCFO 2012-08-21Buy10,000$3.75200.27view
BARABE TIMOTHY CCFO 2012-08-17Buy5,550$3.99182.21view
BARABE TIMOTHY CCFO 2012-08-13Buy4,450$3.99182.21view
Last Andrew J.EVP and GM, GABU 2012-08-03Buy10,000$4.06177.34view
Witney FrankPresident and CEO 2011-08-23Buy20,000$4.74137.55view

Press Releases about AFFX :

Quarterly/Annual Reports about AFFX:

News about AFFX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: PXLW, NGPC, MS, CHMT, AFFX Aug 15 2011 
Affymetrix Inc. (AFFX) CFO Timothy C Barabe buys 5,000 Shares Nov 19 2010 
Affymetrix Inc. (AFFX) CFO Timothy C Barabe buys 10,000 Shares Aug 24 2010 
Weekly CFO Buys Highlight: AspenBio Pharma, Solarwinds, Affymetrix, Cascade Financial Corp., Bank of Jul 31 2010 
Weekly CFO Buys Highlight: Ocean BioChem, Solarwinds Inc., PDL BioPharma, Autobytel Inc., Affymetrix May 08 2010 
Affymetrix Inc. Reports Operating Results (10-Q) May 06 2010 
Weekly CFO Buys Highlight: Ocean BioChem, Affymetrix, Richardson Electronics, First Defiance Financi May 02 2010 
Affymetrix Reports Fourth Quarter and Fiscal Year 2008 Results Jan 28 2009 
Affymetrix to Host Conference Call on January 28, 2009 to Announce Fourth Quarter and Fiscal 2008 Re Jan 27 2009 
Weekly CEO Buys Highlight: ScheringPlough Corp., Novellus Systems Inc., SeaBright Insurance Holdings May 01 2008 

More From Other Websites
Affymetrix Chairman and Founder to Retire from Board of Directors Jan 30 2015
Affymetrix Chairman and Founder to Retire from Board of Directors Jan 30 2015
6:00 am Affymetrix announces that Founder and Chairman, Stephen Fodor, Ph.D., will retire from the... Jan 30 2015
Affymetrix to Report Fourth Quarter and Fiscal Year 2014 Operating Results on Wednesday February 4,... Jan 22 2015
Affymetrix to Report Fourth Quarter and Fiscal Year 2014 Operating Results on Wednesday February 4,... Jan 22 2015
Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity... Jan 21 2015
Affymetrix Hits 52-Week High on Strong Top-Line Growth - Analyst Blog Jan 21 2015
Affymetrix (AFFX) Stock Falls Today on Analyst Downgrade Jan 21 2015
Affymetrix downgraded by Robert W. Baird Jan 21 2015
Amgen (AMGN) Reveals Mixed Results from Vectibix Studies - Analyst Blog Jan 16 2015
Illumina Unveils 3 NGS Systems, Modifies Business Strategy - Analyst Blog Jan 16 2015
Illumina Declares Impressive Q4, 2014 Preliminary Results - Analyst Blog Jan 15 2015
Qiagen Up on CE-IVD Mark for New Liquid Biopsy Test Kit - Analyst Blog Jan 15 2015
uniQure N.V. (QURE) in Focus: Stock Adds 9.6% in Session - Tale of the Tape Jan 15 2015
Intra-Cellular Therapies (ITCI) Jumps: Stock Gains 12.2% - Tale of the Tape Jan 15 2015
Fluidigm's Preliminary Q4 Revenues Up Y/Y, Outlook Positive - Analyst Blog Jan 14 2015
Amgen Maintains 2015 View, Expects Several Drug Launches - Analyst Blog Jan 14 2015
Qiagen Up on Enzymatics' Unit Buy, ArcherDX Partnership Deal - Analyst Blog Jan 14 2015
AFFYMETRIX INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in... Jan 12 2015
— Affymetrix Announces Preliminary Fourth Quarter 2014 Revenue of Approximately $93 Million and... Jan 12 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK